ParagonDx Opens Clinical Diagnostic Laboratory: Launches with Genetic Test for Warfarin Patients
1/8/2009 9:45:49 AM
MORRISVILLE, N.C.--(BUSINESS WIRE)--ParagonDx LLC, a leader in genetic testing diagnostics, is now offering genetic testing for warfarin sensitivity to local doctors and patients. The test helps doctors prevent excessive bleeding in those patients who are taking warfarin (Coumadin©), a common anti-coagulant prescribed to prevent and treat blood clots. By using this test, doctors can understand the genetic component that can help achieve the optimal level of warfarin. This kind of testing has been shown to lower the risk of potential life-threatening adverse drug reactions.
comments powered by